Coeptis Therapeutics Holdings, INC. (COEPW) — 10-Q Filings

All 10-Q filings from Coeptis Therapeutics Holdings, INC.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (5)

Coeptis Assets Surge Amid Widening Losses, Capital Influx — Nov 14, 2025 Risk: high
Coeptis Therapeutics Holdings, Inc. (COEPW) reported a significant increase in total assets to $14,181,641 as of September 30, 2025, up from $8,908,660 at Decem
Coeptis Losses Widen to $7.7M Amid Soaring Professional Service Costs — Aug 14, 2025 Risk: high
Coeptis Therapeutics Holdings, Inc. (COEPW) reported a net loss of $7,755,527 for the six months ended June 30, 2025, an increase from a net loss of $6,036,733
Coeptis Therapeutics Files Q1 2025 10-Q — May 14, 2025 Risk: medium
Coeptis Therapeutics Holdings, Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly Bull Horn Holdings Corp., is involved
Coeptis Therapeutics Files Q3 2024 10-Q — Nov 13, 2024 Risk: medium
Coeptis Therapeutics Holdings, Inc. filed its Q3 2024 10-Q report on November 13, 2024, covering the period ending September 30, 2024. The company, formerly Bul
Coeptis Therapeutics Holdings, Inc. Files 10-Q for Period Ending March 31, 2024 — May 10, 2024 Risk: low
Coeptis Therapeutics Holdings, Inc. (COEPW) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. Coeptis Therapeutics Holdings, Inc. filed a 10-Q for t

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX